Details for 2018731845

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATION EINES MCL-1-INHIBITORS UND STANDARDBEHANDLUNG VON BLUTKREBS, VERWENDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018731845

EP Publication Number

3641775

E-Number

1637760

Language

PCT Number

EP18066551

Publication Date

29.04.2020 A

06.12.2023 B1

Registration Date

06.12.2023

AT Publication Date

15.12.2023

Application Date

21.06.2018

Registration Number

Priorities

22.06.2017

201762523389 P

06.09.2017

17189550

IPC

A61K 31/519 20060101AFI20181231BHEP

Maximum Duration of Protection

21.06.2038

Owner

Les Laboratoires Servier35, rue de Verdun 92284 Suresnes CedexFR

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

WEI, Andrew14 The Avenue Surrey Hills Victoria 3127AU

MOUJALLED, Donia13 Parfrey avenue Lalor Victoria 3075AU

POMILIO, Giovanna33 Pleasant Street Pascoe Vale Victoria 3044AU

GENESTE, Olivier17 rue Crevel Duval 92500 Rueil-MalmaisonFR

MARAGNO, Ana-Leticia4 Allée Anastasi 78290 Croissy-Sur-SeineFR